Latest News

Task force affirms routine gestational diabetes testing


 

FROM JAMA

Support screening with counseling on risk reduction

The USPSTF recommendation is important at this time because “the prevalence of gestational diabetes is increasing secondary to rising rates of obesity,” Iris Krishna, MD, of Emory University, Atlanta, said in an interview.

“In 2014, based on a systematic review of literature, the USPSTF recommended screening all asymptomatic pregnant women for gestational diabetes mellitus [GDM] starting at 24 weeks’ gestation. The recommended gestational age for screening coincides with increasing insulin resistance during pregnancy with advancing gestational age,” Dr. Krishna said.

“An updated systematic review by the USPSTF concluded that existing literature continues to affirm current recommendations of universal screening for GDM at 24 weeks gestation or later. There continues, however, to be no consensus on the optimal approach to screening,” she noted.

“Screening can be performed as a two-step or one-step approach,” said Dr. Krishna. “The two-step approach is commonly used in the United States, and all pregnant women are first screened with a 50-gram oral glucose solution followed by a diagnostic test if they have a positive initial screening.

“Women with risk factors for diabetes, such as prior GDM, obesity, strong family history of diabetes, or history of fetal macrosomia, should be screened early in pregnancy for GDM and have the GDM screen repeated at 24 weeks’ gestation or later if normal in early pregnancy,” Dr. Krishna said. “Pregnant women should be counseled on the importance of diet and exercise and appropriate weight gain in pregnancy to reduce the risk of GDM. Overall, timely diagnosis of gestational diabetes is crucial to improving maternal and fetal pregnancy outcomes.”

The full recommendation statement is also available on the USPSTF website. The research was supported by the Agency for Healthcare Research and Quality. The researchers had no financial conflicts to disclose. Dr. Krishna had no disclosures, but serves on the editorial advisory board of Ob.Gyn News.

Pages

Recommended Reading

Gestational diabetes carries CVD risk years later
MDedge Endocrinology
Algorithm trims time to treatment of acute hypertension in pregnancy
MDedge Endocrinology
Metformin tied to longer gestation in women with preterm preeclampsia
MDedge Endocrinology
Two popular screening tests for gestational diabetes clinically equivalent
MDedge Endocrinology
Obesity: A ‘double hit’ in pregnant women with heart disease
MDedge Endocrinology
Six pregnancy complications flag later heart disease risk
MDedge Endocrinology
USPSTF recommends clinicians counsel pregnant patients to limit gestational weight gain
MDedge Endocrinology
Bariatric surgery leads to better cardiovascular function in pregnancy
MDedge Endocrinology
Screen pregnant women for OSA, given known risks
MDedge Endocrinology
FDA to revise statin pregnancy contraindication
MDedge Endocrinology